Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,080 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06241391 | Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas | unknown | N/A | 35 | All India Institute of Medical Sciences, BhubaneswarOTHER | 1 | Feb 8, 2024 | clinicaltrials |
| NCT06244446 | Efficacy and Safety of SBRT Combined With Atezolizumab Plus Bevacizumab vs Atezolizumab Plus Bevacizumab in Treating Unresectable Advance Hepatocellular Carcinoma. | unknown | — | 40 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 |
| Feb 6, 2024 |
| clinicaltrials |
| NCT00565708 | Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers(ASCOLT) | unknown | Phase 3 | 1,587 | National Cancer Centre, SingaporeOTHER | 10 | Feb 2, 2024 | clinicaltrials |
| NCT01913275 | Comparison Between Endoscopic Stenting and Cholecystojejunostomy for PreoperativeDrainage Before Pancreaticoduodenectomy | withdrawn | N/A | 0 | All India Institute of Medical SciencesOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT03225586 | Prospective Urban Rural Epidemiology Study(PURE) | recruiting | — | 200,000 | Population Health Research InstituteOTHER | 25 | Jan 31, 2024 | clinicaltrials |
| NCT01763645 | A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer | completed | Phase 3 | 353 | BiocadINDUSTRY | 4 | Jan 11, 2024 | clinicaltrials |
| NCT00957086 | Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer | unknown | Phase 3 | 710 | National Cancer Centre, SingaporeOTHER | 13 | Jan 9, 2024 | clinicaltrials |
| NCT02757222 | Dose Escalation Versus Standard in Laryngopharyngeal Cancers(INTELHOPE) | completed | N/A | 100 | Tata Medical CenterOTHER | 1 | Dec 28, 2023 | clinicaltrials |
| NCT03518853 | Short Course Radiotherapy for Localized Prostate Cancer(SHORT) | completed | N/A | 30 | Tata Medical CenterOTHER | 1 | Dec 22, 2023 | clinicaltrials |
| NCT03669497 | Hypo-Fractionated Radiotherapy in Breast Cancer(HYPORT-B) | completed | N/A | 33 | Tata Medical CenterOTHER | 1 | Dec 22, 2023 | clinicaltrials |
| NCT03005860 | Effect of TIVA Propofol vs Sevoflurane Anaesthetic on Serum Biomarkers and on PBMCs in Breast Cancer Surgery | withdrawn | N/A | 0 | Tata Memorial CentreOTHER | 1 | Dec 21, 2023 | clinicaltrials |
| NCT04707196 | A Study of Abemaciclib in Indian Women With Advanced Breast Cancer | completed | Phase 4 | 200 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 24, 2023 | clinicaltrials |
| NCT02139605 | "Phase III Randomized Trial Comparing D2 vs D3 Lymphadenectomy With Gastric Cancer Following Neoadjuvant Chemotherapy | unknown | N/A | 400 | Tata Memorial CentreOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT03677596 | A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients | completed | Phase 4 | 102 | PfizerINDUSTRY | 8 | Nov 22, 2023 | clinicaltrials |
| NCT04297254 | A Study to Assess the Safety and Efficacy of Lenvatinib as First-line Treatment in Participants With Unresectable HCC | completed | Phase 4 | 50 | Eisai Pharmaceuticals India Pvt. LtdINDUSTRY | 1 | Nov 15, 2023 | clinicaltrials |
| NCT01133990 | FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer | terminated | Phase 1 / Phase 2 | 5 | Eisai Inc.INDUSTRY | 5 | Nov 7, 2023 | clinicaltrials |
| NCT06102629 | Ovary Syndrome for Efficient Diagnosis and Targeted Therapy(PCOS-01) | not yet recruiting | N/A | 200 | Asian Institute of Gastroenterology, IndiaOTHER | 1 | Oct 26, 2023 | clinicaltrials |
| NCT02941926 | Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC(COMPLEEMENT-1) | completed | Phase 3 | 3,246 | Novartis PharmaceuticalsINDUSTRY | 38 | Oct 24, 2023 | clinicaltrials |
| NCT05144867 | Stereotactic Radiosurgery vs Whole Brain Radiotherapy in Breast Cancer With Brain Oligometastasis(SRSvsWBRT) | unknown | Phase 3 | 98 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT03761225 | Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer | completed | Phase 3 | 714 | AB ScienceINDUSTRY | 6 | Sep 29, 2023 | clinicaltrials |
| NCT00923702 | Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India | unknown | Phase 4 | 22,729 | Partha BasuOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT06039280 | Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization. | unknown | N/A | 150 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT04801186 | Retrospective Study to Describe the Real-world Treatment Patterns and Associated Clinical Outcomes in Patients With Metastatic Castration-resistant Prostates Cancer(REMPRO) | completed | — | 1,920 | AstraZenecaINDUSTRY | 8 | Sep 7, 2023 | clinicaltrials |
| NCT04046250 | Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690(TK112690) | completed | Phase 2 | 22 | Tosk, Inc.INDUSTRY | 1 | Aug 25, 2023 | clinicaltrials |
| NCT04742192 | Non-interventional, Prospective Study to Determine Prevalence of EGFR Mutations in Non-small Cell Lung Cancer(EARLY-EGFR) | completed | — | 601 | AstraZenecaINDUSTRY | 15 | Aug 14, 2023 | clinicaltrials |
| NCT05658016 | Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690 | unknown | Phase 2 | 24 | Tosk, Inc.INDUSTRY | 1 | Aug 14, 2023 | clinicaltrials |
| NCT05669521 | Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690 | unknown | Phase 2 | 24 | Tosk, Inc.INDUSTRY | 1 | Aug 14, 2023 | clinicaltrials |
| NCT04914195 | Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer | completed | Phase 3 | 155 | Bharat Serums and Vaccines LimitedINDUSTRY | 1 | Aug 1, 2023 | clinicaltrials |
| NCT02303444 | An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors(RIFTOS MKI) | completed | — | 667 | BayerINDUSTRY | 19 | Jun 8, 2023 | clinicaltrials |
| NCT04942054 | A Study in Patients With Advanced Breast Cancer | terminated | Phase 1 | 9 | Sun Pharma Advanced Research Company LimitedINDUSTRY | 2 | May 22, 2023 | clinicaltrials |
| NCT02477124 | A See and Treat Paradigm for Cervical Pre-cancer | terminated | N/A | 514 | Duke UniversityOTHER | 5 | May 18, 2023 | clinicaltrials |
| NCT04111029 | Liquid Biopsy in Hepatocellular Carcinoma(HCCGenePanel) | unknown | — | 30 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT05833841 | Swallowing Function in Patients With Head and Neck Cancers | completed | N/A | 50 | Banaras Hindu UniversityOTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT05113030 | Impact of PCOS on Periodontal Status of Adolescent and Adult Age Group Women | completed | — | 100 | Postgraduate Institute of Dental Sciences RohtakOTHER | 1 | Apr 25, 2023 | clinicaltrials |
| NCT05827458 | An Adequate Cost Effective Follow Up Protocol For Bone and Soft Tissue Sarcomas(TOSS) | completed | — | 500 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 25, 2023 | clinicaltrials |
| NCT05158907 | Patient Reported Scale vs CTCAE Grading: A Prospective Comparator Study(PROSE) | suspended | N/A | 220 | Tata Medical CenterOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05814965 | Association of Apical Periodontitis With Systemic Level of Inflammatory Markers : A Longitudinal Intervention Study | unknown | N/A | 280 | Postgraduate Institute of Dental Sciences RohtakOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT01424566 | A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer | completed | Phase 3 | 406 | Jazz PharmaceuticalsINDUSTRY | 13 | Apr 12, 2023 | clinicaltrials |
| NCT01774019 | Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer | completed | N/A | 284 | Boston Scientific CorporationINDUSTRY | 9 | Apr 10, 2023 | clinicaltrials |
| NCT05801887 | Extracorporeal Shock Wave Therapy on Osteoblast-Like Cells In- Vitro Study(ESWT) | completed | N/A | 20 | Krishnadevaraya College of Dental Sciences & HospitalOTHER | 1 | Apr 6, 2023 | clinicaltrials |
| NCT03449602 | Minirigid Versus Conventional Rigid Thoracoscopy in Undiagnosed Pleural Effusions(MICRO) | unknown | N/A | 100 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT05186610 | FDG PET/CT and Directed Metabolic Core Needle Biopsy in the Management of Lymphoma | completed | — | 480 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Feb 14, 2023 | clinicaltrials |
| NCT02778295 | Biomarker for Patients With Fabry Disease (BioFabry)(BioFabry) | withdrawn | — | 0 | CENTOGENE GmbH RostockINDUSTRY | 3 | Feb 13, 2023 | clinicaltrials |
| NCT02654340 | Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)(TuScCom) | terminated | — | 20 | CENTOGENE GmbH RostockINDUSTRY | 8 | Feb 10, 2023 | clinicaltrials |
| NCT01721876 | Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2) | completed | Phase 3 | 666 | Boehringer IngelheimINDUSTRY | 25 | Feb 8, 2023 | clinicaltrials |
| NCT05716620 | Utility of Abbreviated Magnetic Resonance Imaging as a Screening Tool for Hepatocellular Carcinoma in Cirrhotic Patients | unknown | — | 380 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05718115 | Deep Learning Radiogenomics For Individualized Therapy in Unresectable Gallbladder Cancer | unknown | — | 75 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT03433313 | Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer | completed | Phase 3 | 807 | EirGenix, Inc.INDUSTRY | 11 | Jan 20, 2023 | clinicaltrials |
| NCT00849667 | Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse | terminated | Phase 3 | 1,100 | MorphotekINDUSTRY | 30 | Dec 30, 2022 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials